天目药业：股票连续三日涨幅偏离值累计超20%

Core Viewpoint - The company announced that its stock experienced an abnormal fluctuation, with a cumulative closing price increase of 20% over three consecutive trading days from January 19 to January 21, 2026 [1] Group 1 - The company conducted a self-examination and verified with its controlling shareholder, Huazhe Holdings, confirming that its production and operations are normal [1] - There are no undisclosed significant information or media reports that could have a substantial impact on the stock price [1] - During the period of abnormal fluctuation, the controlling shareholder, directors, and executives did not engage in any buying or selling of the company's stock [1] Group 2 - The company reminds investors to be cautious of trading risks [1]